Mayinglong Pharmaceutical Receives Registration Approval for New Colorectal Treatment
Mayinglong Pharmaceutical Receives Registration Approval for New Colorectal Treatment
马应龙药业获得结直肠新疗法的注册批准
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册